Biopharmaceutics Classification System

For other uses of the abbreviation BCS, please see BCS (disambiguation).

The Biopharmaceutics Classification System is a guidance for predicting the intestinal U.S. Food and Drug Administration [1]. The fundamental basis for the BCS was established by Dr. Gordon Amidon who was presented with a Distinguished Science Award at the August 2006 International Pharmaceutical Federation (FIP) congress in Salvador, Brazil.^{[citation needed]}